Lloyd, Eric E <br/><br/>
Disruption of K(2P)6.1 produces vascular dysfunction and hypertension in mice.  [electronic resource] 

 -  Hypertension (Dallas, Tex. : 1979)  Oct 2011 
 - 672-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1524-4563 
<br/><br/><label>Standard No.: </label>10.1161/HYPERTENSIONAHA.111.175349  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid--pharmacology<br/>3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester--pharmacology<br/>Animals<br/>Aorta--drug effects<br/>Blood Pressure--drug effects<br/>Calcium Channel Agonists--pharmacology<br/>Disease Models, Animal<br/>Hypertension--etiology<br/>Membrane Potentials--drug effects<br/>Mice<br/>Mice, Knockout<br/>Muscle, Smooth, Vascular--drug effects<br/>Potassium Channels, Tandem Pore Domain--deficiency<br/>Potassium Chloride--pharmacology<br/>Vasoconstriction--drug effects<br/>Vasoconstrictor Agents--pharmacology<br/>rho-Associated Kinases--physiology